Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 311

1.

Physician management of pacemaker and implantable cardioverter defibrillator advisories.

Maisel WH.

Pacing Clin Electrophysiol. 2004 Apr;27(4):437-42.

PMID:
15078394
2.

Changing trends in pacemaker and implantable cardioverter defibrillator generator advisories.

Maisel WH, Stevenson WG, Epstein LM.

Pacing Clin Electrophysiol. 2002 Dec;25(12):1670-8.

PMID:
12520666
3.

Clinical judgment versus decision analysis for managing device advisories.

Amin MS, Wood MA, Shepard RK, Kalahasty G, Ellenbogen KA.

Pacing Clin Electrophysiol. 2008 Oct;31(10):1236-40. doi: 10.1111/j.1540-8159.2008.01171.x.

PMID:
18811801
4.

Should recent defibrillator and lead advisories affect decisions to refer patients for implantable cardioverter-defibrillator therapy?

Amin MS, Ellenbogen KA.

Curr Opin Cardiol. 2010 Jan;25(1):23-8. doi: 10.1097/HCO.0b013e328333d375. Review.

PMID:
19907318
5.

Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators.

Maisel WH, Sweeney MO, Stevenson WG, Ellison KE, Epstein LM.

JAMA. 2001 Aug 15;286(7):793-9.

PMID:
11497532
6.

Complications of replacing implantable devices in response to advisories: a single center experience.

Moore JW 3rd, Barrington W, Bazaz R, Jain S, Nemec J, Ngwu O, Schwartzman D, Shalaby A, Saba S.

Int J Cardiol. 2009 May 1;134(1):42-6. doi: 10.1016/j.ijcard.2007.12.070. Epub 2008 Apr 18.

PMID:
18372058
7.

Impact of manufacturer advisories and FDA recalls of implantable cardioverter defibrillator generators in pediatric and congenital heart disease patients.

Mahajan T, Dubin AM, Atkins DL, Bradley DJ, Shannon KM, Erickson CC, Franklin WH, Cecchin F, Berul CI; Members of the Pediatric and Congenital Electrophysiology Society.

J Cardiovasc Electrophysiol. 2008 Dec;19(12):1270-4. doi: 10.1111/j.1540-8167.2008.01259.x. Epub 2008 Aug 8.

PMID:
18691353
8.

Focus on management of pacemaker and ICD advisories, recalls, and alerts.

Amin MS, Ellenbogen KA.

Curr Treat Options Cardiovasc Med. 2006 Sep;8(5):347-52.

PMID:
16939672
9.

Permanent pacemaker and implantable cardioverter defibrillator infections: seven years of diagnostic and therapeutic experience of a single center.

Cengiz M, Okutucu S, Ascioglu S, Sahin A, Aksoy H, Sinan Deveci O, Baris Kaya E, Aytemir K, Kabakci G, Tokgozoglu L, Ozkutlu H, Oto A.

Clin Cardiol. 2010 Jul;33(7):406-11. doi: 10.1002/clc.20765.

10.

Complications associated with generator replacement in response to device advisories.

Costea A, Rardon DP, Padanilam BJ, Fogel RI, Prystowsky EN.

J Cardiovasc Electrophysiol. 2008 Mar;19(3):266-9. Epub 2007 Dec 12.

PMID:
18081773
11.

Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories.

Gould PA, Krahn AD; Canadian Heart Rhythm Society Working Group on Device Advisories.

JAMA. 2006 Apr 26;295(16):1907-11.

PMID:
16639049
12.

Outcome of advisory implantable cardioverter-defibrillator replacement: one-year follow-up.

Gould PA, Gula LJ, Champagne J, Healey JS, Cameron D, Simpson C, Thibault B, Pinter A, Tung S, Sterns L, Birnie D, Exner D, Parkash R, Skanes AC, Yee R, Klein GJ, Krahn AD.

Heart Rhythm. 2008 Dec;5(12):1675-81. doi: 10.1016/j.hrthm.2008.09.020. Epub 2008 Sep 23.

PMID:
19084804
13.

Utilization of a national network for rapid response to the Medtronic Fidelis lead advisory: the Canadian Heart Rhythm Society Device Advisory Committee.

Krahn AD, Simpson CS, Parkash R, Yee R, Champagne J, Healey JS, Cameron D, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Sanatani S, Gow R, Connors S, Paredes FA, Turabian M, Kus T, Gardner M, Essebag V.

Heart Rhythm. 2009 Apr;6(4):474-7. doi: 10.1016/j.hrthm.2009.01.012. Epub 2009 Jan 18.

PMID:
19324305
14.

Survey of cardiac rhythm management and device implant patterns in Puerto Rico: analysis of 13,854 cardiac implants.

Aranda JM, Girod M, Ochoa F, Abreu M, Rivera JJ, Sotomonte JC, Rodríguez A, Arzola D, Fiménez R, Aranda JM Jr.

Bol Asoc Med P R. 2008 Jan-Mar;100(1):39-49.

PMID:
18763396
15.

[Postmarketing surveillance in patients with cardiac pace-makers or automatic implantable defibrillators].

Fauchier L, de Bouët du Portal H, Giraudeau C, Froger S, Cosnay P, Babuty D.

Ann Cardiol Angeiol (Paris). 2005 Jan;54(1):38-43. Review. French.

PMID:
15702910
16.

Recall alerts in implantable cardioverter-defibrillator recipients: implications for patients and physicians.

Schwartz J, Blangy H, Zinzius PY, Freysz L, Aliot E, Sadoul N.

Pacing Clin Electrophysiol. 2011 Jan;34(1):96-103. doi: 10.1111/j.1540-8159.2010.02918.x. Epub 2010 Oct 7.

PMID:
21039641
17.

The effect of device advisories on implantable cardioverter-defibrillator therapy.

Amin MS, Ellenbogen KA.

Curr Cardiol Rep. 2010 Sep;12(5):361-6. doi: 10.1007/s11886-010-0124-7.

PMID:
20512632
18.

[Recommendations for protection against electromagnetic interference risk caused by pacemakers and implantable defibrillators in hospitals].

Santomauro M, Da Prato D, Ottaviano L, Borrelli A, Chiariello M.

Ital Heart J Suppl. 2002 Apr;3(4):440-5. Italian.

PMID:
12025389
19.

Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity.

Sengupta J, Kendig AC, Goormastic M, Hwang ES, Ching EA, Chung R, Lindsay BD, Tchou PJ, Wilkoff BL, Niebauer MJ, Martin DO, Varma N, Wazni O, Saliba W, Kanj M, Bhargava M, Dresing T, Taigen T, Ingelmo C, Bassiouny M, Cronin EM, Wilsmore B, Rickard J, Chung MK.

Heart Rhythm. 2012 Oct;9(10):1619-26. doi: 10.1016/j.hrthm.2012.07.002. Epub 2012 Jul 3.

20.

Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006.

Kurtz SM, Ochoa JA, Lau E, Shkolnikov Y, Pavri BB, Frisch D, Greenspon AJ.

Pacing Clin Electrophysiol. 2010 Jun 1;33(6):705-11. doi: 10.1111/j.1540-8159.2009.02670.x. Epub 2010 Jan 4.

PMID:
20059714
Items per page

Supplemental Content

Write to the Help Desk